RE:RE:1.2B Shares out........is that a joke?Take a look around at other stocks in this space, you'll note a fair bit of dilution due to financing a business that has no revenue streams, but are looking to carry these companies thru its research and clinical trials etc. At least Neovasc is close with regulatory approvals in Europe, the Middle East, and the U.S.A. and Canada with revenue streams and a significant forecast for 2019. Do read everything the Company has released. There is no secret or irrational judgement made by market analyst here giving Neovasc a Strong Buy recommendation. They see this as having greater significance sooner than later. Here to good fortune!